Previous close | 233.15 |
Open | 208.10 |
Bid | 206.95 |
Ask | 212.60 |
Strike | 840.00 |
Expiry date | 2025-12-19 |
Day's range | 208.00 - 208.10 |
Contract range | N/A |
Volume | |
Open interest | 96 |
Stocks of LLY, VKTX and GPCR, which make oral pills for obesity, rose on Wednesday in response to Novo Nordisk's positive data.
Eli Lilly halved the price of a new version of its weight-loss drug, Zepbound. Is Eli Lilly stock a buy right now?
NVO stock gains 4.2% after it presents efficacy data superior to Wegovy for its new oral pill, amycretin, in an early-stage study.